Back
Structure Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
GPCR
Structure Therapeutics
Last Price:
$23.77
Seasonality Move:
18.95%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.
Structure Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.01 | Buy |
| 20-day SMA: | 18.55 | Buy |
| 50-day SMA: | 20.57 | Buy |
| 200-day SMA: | 31.59 | Sell |
| 8-day EMA: | 22 | Buy |
| 20-day EMA: | 20.31 | Buy |
| 50-day EMA: | 21.33 | Buy |
| 200-day EMA: | 29.28 | Sell |
Structure Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.85 | Buy |
| Relative Strength Index (14 RSI): | 65.79 | Buy |
| Chaikin Money Flow: | 66433 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.83 - 22.03) | Buy |
| Bollinger Bands (100): | (19.73 - 29.99) | Sell |
Structure Therapeutics Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 23.74 while GPCR 8-day simple moving average is 22.01, which is a Buy signal.
-
The stock price of GPCR is 23.74 while Structure Therapeutics 20-day SMA is 18.55, which makes it a Buy.
-
Structure Therapeutics 50-day simple moving average is 20.57 while GPCR share price is 23.74, making it a Buy technically.
-
GPCR stock price is 23.74 and Structure Therapeutics 200-day simple moving average is 31.59, creating a Sell signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
44
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a SellThe current Structure Therapeutics [GPCR] share price is $23.74. The Score for GPCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics Stock Info
Market Cap:
1.4B
Price in USD:
23.74
Share Volume:
731.8K
Structure Therapeutics 52-Week Range
52-Week High:
62.74
52-Week Low:
13.22
Sell
44
Structure Therapeutics (GPCR)
is a Sell
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?The Structure Therapeutics stock price is 23.74 USD today.
-
Will GPCR stock go up or go down?Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Structure Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is overvalued.
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 23.74 while GPCR 8-day exponential moving average is 22.00, which is a Buy signal.
-
The stock price of GPCR is 23.74 while Structure Therapeutics 20-day EMA is 20.31, which makes it a Buy.
-
Structure Therapeutics 50-day exponential moving average is 21.33 while GPCR share price is 23.74, making it a Buy technically.
-
GPCR stock price is 23.74 and Structure Therapeutics 200-day simple moving average is 29.28, creating a Sell signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.08 per share, and a decrease next year of $0.68 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
-
GPCR Moving Average Covergence Divergence (MACD) indicator is 0.85, suggesting Structure Therapeutics is a Buy
-
Structure Therapeutics Relative Strength Index (RSI) is 65.79, which suggest Structure Therapeutics is overbought
-
The Bollinger Bands (25) for Structure Therapeutics is (15.83 - 22.03), which suggest Structure Therapeutics is a Sell
-
The Bollinger Bands (100) for Structure Therapeutics is (19.73 - 29.99), which suggest Structure Therapeutics is a Sell
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.